PIK3CA and esophageal squamous cell carcinoma: PIK3CA has been named as the key oncogenic effector and could be a potential driver mutation in tumorigenesis of ESCC [35] and these mutants have previously shown oncogenic effects in vivo and may act as a p otential target site of treatment as in other cancer types[36].